Invesaro

Stocks PCYN Financial statements

Financial statements

PROCYON CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PROCYON CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue2.773.454.014.024.194.334.724.844.694.98
Cost of revenue0.811.031.261.081.141.131.331.361.121.09
Gross profit1.962.422.752.943.053.23.393.493.573.89
Research and development0.020.020.030.040.030.020.030.030.030.03
Selling, general and administrative1.051.071.151.311.421.321.331.711.812.04
Selling and marketing0.450.48
Operating income-0.34-0.10.030.130.10.150.23-0.24-0.1-0.23
Interest expense0000000000
Interest income00.010.02
Other non-operating income00.29-0000.010.5100.030.06
Pre-tax income-0.340.190.030.130.10.160.73-0.24-0.07-0.17
Income tax0.120.080.020.380.070.050.04-0.03-0.020.17
Net income-0.240.110.01-0.260.030.110.69-0.21-0.05-0.34
EBITDA-0.31-0.070.080.170.150.210.27-0.2-0.04-0.15
EPS, basic-0.030.010.00-0.030.000.010.08-0.03-0.01-0.04
EPS, diluted-0.030.010.00-0.030.000.010.08-0.03-0.01-0.04
Shares, basic (weighted)8.068.068.068.088.098.098.098.098.098.12
Shares, diluted (weighted)8.068.258.288.088.328.328.328.098.098.12

Balance sheet

FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash and equivalents0.20.060.170.270.290.671.230.760.450.33
Receivables0.260.540.390.370.420.310.50.410.490.51
Inventory0.430.690.510.420.490.760.590.760.430.51
Other current assets0.20.170.180.170.240.180.280.370.30.43
Total current assets1.351.881.351.381.592.072.872.592.242.37
Property, plant and equipment0.50.540.510.510.490.450.110.150.280.26
Lease right-of-use assets0.030.880.710.530.34
Intangible assets00.020.020.020.020.020.020.020.02
Other non-current assets0.670.560.760.460.35
Total assets2.523.122.732.362.432.824.273.83.563.2
Accounts payable0.120.360.120.10.150.170.170.180.180.16
Accrued liabilities0.160.36
Deferred revenue0.10.13
Total current liabilities0.360.840.440.330.380.510.740.640.630.77
Long-term debt0.14
Lease liabilities0.650.490.320.14
Total liabilities0.360.850.440.330.380.661.391.130.950.92
Paid-in capital0.010.010.020.020.020.020.040.040.040.04
Retained earnings-2.42-2.31-2.3-2.56-2.53-2.42-1.73-1.94-1.99-2.33
Shareholders' equity2.162.272.292.032.062.162.882.672.622.29
Total equity2.162.272.292.032.062.162.882.672.622.29
Total liabilities and equity2.523.122.732.362.432.824.273.83.563.2
Shares outstanding8.068.068.088.088.098.098.098.098.098.12

Cash flow statement

FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Net income-0.220.110.01-0.260.030.110.69-0.21-0.05-0.34
Depreciation and amortization0.040.040.050.050.050.050.040.040.050.08
Stock-based compensation-00.0100000.02000.01
Deferred income tax-0.120.080.020.380.070.05
Change in receivables-0.03-0.270.150.02-0.050.11-0.190.09-0.08-0.02
Change in inventory0.16-0.250.110-0.03-0.23-0.01-0.090.180.04
Change in payables0.010.24-0.24-0.030.050.0200.01-0-0.01
Cash from operations-0.390.020.20.090.050.20.28-0.380.15-0.06
Capital expenditures-0.07-0.07-0.02-0.05-0.03-0.02-0.07-0.08-0.18-0.06
Cash from investing-0.07-0.210.040.01-0.03-0.020.48-0.08-0.45-0.06
Debt issued0.200
Stock issued0.01
Cash from financing0.080.04-0.13-0-00.2-0.2000
Net change in cash-0.150.110.10.020.380.56-0.47-0.31-0.13
Free cash flow-0.46-0.050.180.040.020.180.21-0.47-0.03-0.13
Interest paid0000000
Income taxes paid0000

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $0.27 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin78.1%Gross profit / revenue.
Operating margin-4.6%Operating income / revenue.
EBITDA margin-3.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-3.4%Pre-tax income / revenue.
Net margin-6.8%Net income / revenue.
FCF margin-2.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-1.2%Cash from operations / revenue.
Return on equity (ROE)-13.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-10.1%Net income / average total assets.
Return on invested capital (ROIC)-8.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue0.6%Research and development expense / revenue.
SG&A / revenue40.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.3%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y3.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y9.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-142.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-12.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-7.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y2.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-10.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-9.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.08xCurrent assets / current liabilities.
Quick ratio1.09x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.42x(Cash + short-term investments) / current liabilities.
Liabilities / assets28.6%Total liabilities / total assets.
Working capital$1.6MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.5%(Goodwill + intangible assets) / total assets.
Tangible book value$2.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.47xRevenue / average total assets.
Fixed asset turnover18.4xRevenue / average property, plant and equipment.
Inventory turnover2.32xCost of revenue / average inventory.
Days inventory157 days365 x average inventory / cost of revenue.
Receivables turnover9.90xRevenue / average receivables.
Days sales outstanding37 days365 x average receivables / revenue.
Days payables56 days365 x average accounts payable / cost of revenue.
Cash conversion cycle138 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.04Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.04Net income per basic share, as reported (split-adjusted).
Revenue per share$0.61Revenue / diluted weighted shares.
FCF per share-$0.02Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.01Cash from operations / diluted weighted shares.
Book value per share$0.28Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.28Tangible book value / shares outstanding.
Cash per share$0.04(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$2.2MShare price x shares outstanding.
Enterprise value$1.9MMarket cap + total debt - cash - short-term investments.
P/S0.44xMarket cap / revenue.
P/B0.96xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.97xMarket cap / tangible book value, when positive.
EV/Sales0.37xEnterprise value / revenue.
FCF yield-5.7%Free cash flow / market cap.
Earnings yield-15.6%Net income / market cap (the inverse of P/E).
What was PROCYON CORP's revenue in fiscal 2024?

PROCYON CORP reported revenue of $5.0M for fiscal 2024, 6.4% higher than the year before.

Was PROCYON CORP profitable in fiscal 2024?

No. It reported a net loss of $341.1K.

How much free cash flow did PROCYON CORP generate in fiscal 2024?

Cash from operations of $61.3K minus capital expenditures of $63.9K left free cash flow of -$125.2K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PROCYON CORP